SCHEMBL13628307

SCHEMBL13628307

COC(=O)c1ccc(CNC(=O)c2cccc(CCNC(=O)[C@]34CC[C@@H](C5(C)CO5)C3C3CCC5[C@@]6(C)CC[C@H](O)C(C)(C)C6CC[C@@]5(C)[C@]3(C)CC4)c2)nc1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 1/20 0.49
▸ RORC P51449 14/20 0.48
▸ TRPV1 Q8NER1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13637464 0.90 TRPV1 (0.48) GPBAR1RORCTRPV1
SCHEMBL13637776 0.89 TRPV1 (0.42) RORCTRPV1
SCHEMBL13628310 0.87 RORC (0.58) GPBAR1RORCTRPV1
SCHEMBL13628305 0.86 RORC (0.45) RORCTRPV1
SCHEMBL4453635 0.85 TRPV1 (0.51) RORCTRPV1
SCHEMBL13628481 0.84 RORC (0.58) RORCTRPV1
SCHEMBL13628624 0.84 RORC (0.44) RORCTRPV1
SCHEMBL4451279 0.84 RORC (0.44) RORCTRPV1
SCHEMBL13637471 0.84 RORC (0.48) GPBAR1RORCTRPV1
SCHEMBL4451644 0.84 RORC (0.48) GPBAR1RORCTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275583-A1 ANTIVIRAL COMPOUNDS AND USE THEREOF MYRIAD GENETICS, INCORPORATED (US) 2009-11-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275583-A1 ANTIVIRAL COMPOUNDS AND USE THEREOF MAVS, ZC3HAV1, EIF2AK2 GPBAR1 3262/4885RORC 514/4885TRPV1 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback